Literature DB >> 20736

Evidence of decarboxylation of lysine by mammalian ornithine decarboxylase.

L Persson.   

Abstract

In enzymic preparations from mouse kidney stimulated with the anabolic steroid Durabolin (nandrolone phenpropionate) lysine and ornithine were shown to inhibit the decarboxylation of each other competitively. The Michaelis constants for the decarboxylations were approximately equal to the inhibition constants of the two amino acids. The pH optima of the decarboxylation of lysine and ornithine were found to be identical. Chromatographic studies of the enzyme preparation on a Sephadex G-150 Superfine column did not bring about a separation of the two enzyme activities. The ratio of the decarboxylating activities was practically the same during the elution. Lysine decarboxylating activity was also shown to be present in growth hormone stimulated rat liver. The results are in agreement with the assumption that the decarboxylation of lysine and ornithine is carried out by the same enzyme.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 20736     DOI: 10.1111/j.1748-1716.1977.tb05966.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  4 in total

1.  Specificity of mammalian spermidine synthase and spermine synthase.

Authors:  A E Pegg; K Shuttleworth; H Hibasami
Journal:  Biochem J       Date:  1981-08-01       Impact factor: 3.857

2.  Identification of essential active-site residues in ornithine decarboxylase of Nicotiana glutinosa decarboxylating both L-ornithine and L-lysine.

Authors:  Y S Lee; Y D Cho
Journal:  Biochem J       Date:  2001-12-15       Impact factor: 3.857

3.  Cadaverine formation by specific lysine decarboxylation in Pisum sativum seedlings.

Authors:  M Bakhanashvili; I Icekson; A Apelbaum
Journal:  Plant Cell Rep       Date:  1985-12       Impact factor: 4.570

4.  Pilot Study on Acute Effects of Pharmacological Intraperitoneal L-Homoarginine on Homeostasis of Lysine and Other Amino Acids in a Rat Model of Isoprenaline-Induced Takotsubo Cardiomyopathy.

Authors:  Dimitrios Tsikas; Björn Redfors
Journal:  Int J Mol Sci       Date:  2022-04-25       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.